Cargando…

Rising CNS Polypharmacy Among Older Adults in the United States

CNS-polypharmacy is defined by the AGS Beers Criteria as using 3 or more individual medications from the following classes: antidepressants, antipsychotics, benzodiazepines, other sedative/hypnotics, opioids, antiepileptics. Dr. Maust will review data suggesting that such prescribing has increased a...

Descripción completa

Detalles Bibliográficos
Autor principal: Maust, Donovan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743137/
http://dx.doi.org/10.1093/geroni/igaa057.2689
_version_ 1783624146370953216
author Maust, Donovan
author_facet Maust, Donovan
author_sort Maust, Donovan
collection PubMed
description CNS-polypharmacy is defined by the AGS Beers Criteria as using 3 or more individual medications from the following classes: antidepressants, antipsychotics, benzodiazepines, other sedative/hypnotics, opioids, antiepileptics. Dr. Maust will review data suggesting that such prescribing has increased among older adults, along with the data suggesting there are associated harms. In addition, he will review recent evidence from the Department of Veterans Affairs, which suggests that older Veterans who use both Medicare and the VA system for medical care are at higher risk of potentially inappropriate CNS-active prescribing. Part of a symposium sponsored by the Aging, Alcohol and Addictions Interest Group.
format Online
Article
Text
id pubmed-7743137
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77431372020-12-21 Rising CNS Polypharmacy Among Older Adults in the United States Maust, Donovan Innov Aging Abstracts CNS-polypharmacy is defined by the AGS Beers Criteria as using 3 or more individual medications from the following classes: antidepressants, antipsychotics, benzodiazepines, other sedative/hypnotics, opioids, antiepileptics. Dr. Maust will review data suggesting that such prescribing has increased among older adults, along with the data suggesting there are associated harms. In addition, he will review recent evidence from the Department of Veterans Affairs, which suggests that older Veterans who use both Medicare and the VA system for medical care are at higher risk of potentially inappropriate CNS-active prescribing. Part of a symposium sponsored by the Aging, Alcohol and Addictions Interest Group. Oxford University Press 2020-12-16 /pmc/articles/PMC7743137/ http://dx.doi.org/10.1093/geroni/igaa057.2689 Text en © The Author(s) 2020. Published by Oxford University Press on behalf of The Gerontological Society of America. http://creativecommons.org/licenses/by/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstracts
Maust, Donovan
Rising CNS Polypharmacy Among Older Adults in the United States
title Rising CNS Polypharmacy Among Older Adults in the United States
title_full Rising CNS Polypharmacy Among Older Adults in the United States
title_fullStr Rising CNS Polypharmacy Among Older Adults in the United States
title_full_unstemmed Rising CNS Polypharmacy Among Older Adults in the United States
title_short Rising CNS Polypharmacy Among Older Adults in the United States
title_sort rising cns polypharmacy among older adults in the united states
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7743137/
http://dx.doi.org/10.1093/geroni/igaa057.2689
work_keys_str_mv AT maustdonovan risingcnspolypharmacyamongolderadultsintheunitedstates